Trademark: 78757131
Word
PDL BIOPHARMA
Status
Dead
Status Code
606
Status Date
Monday, December 8, 2008
Serial Number
78757131
Mark Type
3000
Filing Date
Friday, November 18, 2005
Published for Opposition
Tuesday, August 8, 2006
Abandoned Date
Monday, December 8, 2008

Trademark Owner History
PDL BioPharma, Inc - 1st New Owner After Publication
Protein Design Labs, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations, namely those for the treatment, prevention and diagnosis of allergies, autoimmune deficiencies, cardiovascular, inflammatory, ophthalmic, oncological, and organ transplant-related conditions and diseases
Color is not claimed as a feature of the mark.
PROTEIN DESIGN LABS BIOPHARMA

Trademark Events
Dec 8, 2008
Abandonment Notice Mailed - No Use Statement Filed
Dec 8, 2008
Abandonment - No Use Statement Filed
Feb 13, 2008
Extension 3 Granted
Feb 13, 2008
Extension 3 Filed
Feb 13, 2008
Teas Extension Received
Oct 31, 2007
Extension 2 Granted
Oct 19, 2007
Extension 2 Filed
Oct 19, 2007
Teas Extension Received
Oct 18, 2007
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 18, 2007
Teas Change Of Owner Address Received
Oct 18, 2007
Teas Change Of Correspondence Received
Aug 3, 2007
Extension 1 Granted
Apr 30, 2007
Extension 1 Filed
Apr 30, 2007
Teas Extension Received
Oct 31, 2006
Noa Mailed - Sou Required From Applicant
Sep 27, 2006
Assignment Of Ownership Not Updated Automatically
Aug 8, 2006
Published For Opposition
Jul 19, 2006
Notice Of Publication
Jun 19, 2006
Law Office Publication Review Completed
Jun 9, 2006
Assigned To Lie
Jun 5, 2006
Approved For Pub - Principal Register
Jun 5, 2006
Examiner's Amendment Entered
Jun 5, 2006
Examiners Amendment E-Mailed
Jun 5, 2006
Examiners Amendment -Written
Dec 6, 2005
Examiner's Amendment/Priority Action E-Mailed
Dec 6, 2005
Examiners Amendment And/Or Priority Action - Completed
Dec 6, 2005
Assigned To Examiner
Nov 26, 2005
Notice Of Design Search Code Mailed
Nov 25, 2005
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24